AU Stock MarketDetailed Quotes

OSLO OncoSil Medical Ltd

Watchlist

0.001
0.0000.00%

20min DelayTrading Jul 2 10:06 AET

3.33MMarket Cap0.00P/E (Static)

OncoSil Medical Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

(FY)Jun 30, 2019

(FY)Jun 30, 2018

Total revenue

58.63%367.68K

8.79%231.79K

213.07K

Operating revenue

58.63%367.68K

8.79%231.79K

--213.07K

----

Cost of revenue

63.37%1.59M

1.19%972.47K

961.02K

Gross profit

-64.86%-1.22M

0.97%-740.69K

-747.95K

Operating expense

6.60%11.51M

-2.43%10.8M

50.35%11.06M

-40.89%7.36M

-9.79%12.45M

13.8M

Selling and administrative expenses

-6.71%6.69M

7.80%7.17M

291.08%6.65M

-69.75%1.7M

-10.55%5.62M

--6.29M

-Selling and marketing expense

-64.77%130.42K

-45.94%370.21K

--684.77K

----

-General and administrative expense

-3.55%6.56M

13.96%6.8M

250.82%5.97M

-69.75%1.7M

-10.55%5.62M

--6.29M

Research and development costs

19.97%2.85M

-17.70%2.38M

-22.50%2.89M

-33.18%3.73M

-3.53%5.58M

--5.78M

Depreciation amortization depletion

38.60%175.89K

-31.32%126.91K

23.77%184.78K

286.59%149.29K

-3.25%38.62K

--39.91K

-Depreciation and amortization

38.60%175.89K

-31.32%126.91K

23.77%184.78K

286.59%149.29K

-3.25%38.62K

--39.91K

Other operating expenses

59.77%1.79M

-16.26%1.12M

-24.83%1.34M

47.04%1.78M

-28.48%1.21M

--1.69M

Operating profit

-10.34%-12.73M

2.33%-11.54M

-60.51%-11.81M

40.89%-7.36M

9.79%-12.45M

-13.8M

Net non-operating interest income (expenses)

644.69%51.71K

-114.22%-9.49K

-28.85%66.74K

-54.05%93.8K

41.00%204.11K

144.76K

Non-operating interest income

517.97%62.61K

-87.72%10.13K

-21.36%82.48K

-48.62%104.88K

41.00%204.11K

--144.76K

Non-operating interest expense

--5

----

25.55%1.08K

--861

----

Total other finance cost

-44.48%10.9K

33.81%19.62K

43.45%14.67K

--10.22K

----

Other net income (expenses)

67.44%1.16M

-38.58%692.11K

-60.51%1.13M

-21.62%2.85M

-28.85%3.64M

5.12M

Other non-operating income (expenses)

67.44%1.16M

-38.58%692.11K

-60.51%1.13M

-21.62%2.85M

-28.85%3.64M

--5.12M

Income before tax

-5.74%-11.34M

-2.81%-10.73M

-144.81%-10.43M

50.25%-4.26M

-0.32%-8.57M

-8.54M

Income tax

Earnings from equity interest net of tax

Net income

-5.74%-11.34M

-2.81%-10.73M

-144.81%-10.43M

50.25%-4.26M

-0.32%-8.57M

-8.54M

Net income continuous operations

-5.74%-11.34M

-2.81%-10.73M

-144.81%-10.43M

50.25%-4.26M

-0.32%-8.57M

---8.54M

Noncontrolling interests

Net income attributable to the company

-5.74%-11.34M

-2.81%-10.73M

-144.81%-10.43M

50.25%-4.26M

-0.32%-8.57M

-8.54M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-5.74%-11.34M

-2.81%-10.73M

-144.81%-10.43M

50.25%-4.26M

-0.32%-8.57M

-8.54M

Diluted earnings per share

Basic earnings per share

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020	(FY)Jun 30, 2019	(FY)Jun 30, 2018
Total revenue	58.63%367.68K	8.79%231.79K	213.07K
Operating revenue	58.63%367.68K	8.79%231.79K	--213.07K	----	----	----
Cost of revenue	63.37%1.59M	1.19%972.47K	961.02K
Gross profit	-64.86%-1.22M	0.97%-740.69K	-747.95K
Operating expense	6.60%11.51M	-2.43%10.8M	50.35%11.06M	-40.89%7.36M	-9.79%12.45M	13.8M
Selling and administrative expenses	-6.71%6.69M	7.80%7.17M	291.08%6.65M	-69.75%1.7M	-10.55%5.62M	--6.29M
-Selling and marketing expense	-64.77%130.42K	-45.94%370.21K	--684.77K	----	----	----
-General and administrative expense	-3.55%6.56M	13.96%6.8M	250.82%5.97M	-69.75%1.7M	-10.55%5.62M	--6.29M
Research and development costs	19.97%2.85M	-17.70%2.38M	-22.50%2.89M	-33.18%3.73M	-3.53%5.58M	--5.78M
Depreciation amortization depletion	38.60%175.89K	-31.32%126.91K	23.77%184.78K	286.59%149.29K	-3.25%38.62K	--39.91K
-Depreciation and amortization	38.60%175.89K	-31.32%126.91K	23.77%184.78K	286.59%149.29K	-3.25%38.62K	--39.91K
Other operating expenses	59.77%1.79M	-16.26%1.12M	-24.83%1.34M	47.04%1.78M	-28.48%1.21M	--1.69M
Operating profit	-10.34%-12.73M	2.33%-11.54M	-60.51%-11.81M	40.89%-7.36M	9.79%-12.45M	-13.8M
Net non-operating interest income (expenses)	644.69%51.71K	-114.22%-9.49K	-28.85%66.74K	-54.05%93.8K	41.00%204.11K	144.76K
Non-operating interest income	517.97%62.61K	-87.72%10.13K	-21.36%82.48K	-48.62%104.88K	41.00%204.11K	--144.76K
Non-operating interest expense	--5	----	25.55%1.08K	--861	----	----
Total other finance cost	-44.48%10.9K	33.81%19.62K	43.45%14.67K	--10.22K	----	----
Other net income (expenses)	67.44%1.16M	-38.58%692.11K	-60.51%1.13M	-21.62%2.85M	-28.85%3.64M	5.12M
Other non-operating income (expenses)	67.44%1.16M	-38.58%692.11K	-60.51%1.13M	-21.62%2.85M	-28.85%3.64M	--5.12M
Income before tax	-5.74%-11.34M	-2.81%-10.73M	-144.81%-10.43M	50.25%-4.26M	-0.32%-8.57M	-8.54M
Income tax	0	0	0	0	0	0
Earnings from equity interest net of tax
Net income	-5.74%-11.34M	-2.81%-10.73M	-144.81%-10.43M	50.25%-4.26M	-0.32%-8.57M	-8.54M
Net income continuous operations	-5.74%-11.34M	-2.81%-10.73M	-144.81%-10.43M	50.25%-4.26M	-0.32%-8.57M	---8.54M
Noncontrolling interests
Net income attributable to the company	-5.74%-11.34M	-2.81%-10.73M	-144.81%-10.43M	50.25%-4.26M	-0.32%-8.57M	-8.54M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-5.74%-11.34M	-2.81%-10.73M	-144.81%-10.43M	50.25%-4.26M	-0.32%-8.57M	-8.54M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall